Bank of America
BLTE

Bank of America’s Belite Bio BLTE Stock Holding History

Bank of America’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$602K Buy
3,778
+1,926
+104% +$324K ﹤0.01% 4800
2025
Q4 		$296K Buy
1,852
+681
+58% +$80.7K ﹤0.01% 5159
2025
Q3 		$86.7K Buy
1,171
+257
+28% +$16.9K ﹤0.01% 6656
2025
Q2 		$52.7K Sell
914
-4,310
-83% -$263K ﹤0.01% 6793
2025
Q1 		$346K Sell
5,224
-13,118
-72% -$790K ﹤0.01% 5861
2024
Q4 		$1.16M Buy
18,342
+4,891
+36% +$322K ﹤0.01% 4905
2024
Q3 		$631K Buy
13,451
+13,349
+13,087% +$647K ﹤0.01% 5349
2024
Q2 		$4.66K Sell
102
-1,622
-94% -$70.2K ﹤0.01% 7021
2024
Q1 		$66.2K Sell
1,724
-482
-22% -$21.6K ﹤0.01% 6422
2023
Q4 		$101K Buy
2,206
+2,143
+3,402% +$82.4K ﹤0.01% 6373
2023
Q3 		$2.01K Buy
+63
New +$1.58K ﹤0.01% 7142

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America's BLTE Position: Q1 2026 in Review

Bank of America increased its Belite Bio (BLTE) stake by 104% in Q1 2026, buying an estimated $324K and bringing the position to 3,778 shares worth $602K. The position accounts for ﹤0.01% of the portfolio, ranked #4800.

Bank of America first reported a position in BLTE in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.16M in Q4 2024. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • Bank of America held 3,778 shares of Belite Bio worth $602K as of Q1 2026.
  • Bank of America bought 1,926 Belite Bio shares in Q1 2026, an estimated $324K.
  • Belite Bio made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4800 holding.
  • Bank of America first reported a position in Belite Bio in Q3 2023 and has held it in 11 quarters since.
  • Bank of America's Belite Bio position peaked at $1.16M in Q4 2024.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.